5 Key Facts About Eli Lilly You Need to Know NOW

Eli Lilly stock, LLY stock analysis, Mounjaro, Zepbound, tirzepatide, diabetes drugs, weight loss medication, pharmaceutical stocks, biotech investing, Novo Nordisk competition, GLP-1 drugs, Alzheimer's treatment, FDA approval, stock market analysis, healthcare investing, drug pipeline, analyst price targets, Q2 2025 earnings, market cap analysis, SWOT analysis, investment strategy, financial performance, blockbuster drugs, Verzenio, Trulicity, clinical trials, pharmaceutical industry, stock predictions 2025